317 related articles for article (PubMed ID: 19799143)
21. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
[TBL] [Abstract][Full Text] [Related]
22. Japanese encephalitis: development of new candidate vaccines.
Bharati K; Vrati S
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
Liu W; Clemens JD; Kari K; Xu ZY
Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
[TBL] [Abstract][Full Text] [Related]
25. [Analysis on data from the clinical acute viral encephalitis surveillance system in three prefectures in Shaanxi during 2005 - 2006].
Zhang SB; Yin ZD; Suraratdecha C; Hills SL; Liu XZ; Li YX; Xia XQ; Liang GD; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):895-8. PubMed ID: 19173854
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and burden of disease from Japanese encephalitis in Cambodia: results from two years of sentinel surveillance.
Touch S; Hills S; Sokhal B; Samnang C; Sovann L; Khieu V; Soeung SC; Toda K; Robinson J; Grundy J
Trop Med Int Health; 2009 Nov; 14(11):1365-73. PubMed ID: 19747185
[TBL] [Abstract][Full Text] [Related]
27. [The progress and challenge of Japanese encephalitis control and prevention in China].
Wang HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Feb; 53(2):133-135. PubMed ID: 30744284
[TBL] [Abstract][Full Text] [Related]
28. Japanese encephalitis in mainland china.
Wang H; Li Y; Liang X; Liang G
Jpn J Infect Dis; 2009 Sep; 62(5):331-6. PubMed ID: 19762980
[TBL] [Abstract][Full Text] [Related]
29. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
[TBL] [Abstract][Full Text] [Related]
30. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Sabchareon A; Pancharoen C; Bouckenooghe A; Gailhardou S; Boaz M; Feroldi E
Pediatr Infect Dis J; 2010 Dec; 29(12):1111-7. PubMed ID: 20856164
[TBL] [Abstract][Full Text] [Related]
32. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR; Gore MM
Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
[TBL] [Abstract][Full Text] [Related]
33. [A survey of Japanese encephalitis antibody migrant workers in Shenzhen 2009].
Shan FX; Cheng JQ; Mou J; Zhang SY; He YQ; Xiao JH; Chen YJ; Huang WG; Xiong LE
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Sep; 44(9):806-9. PubMed ID: 21092624
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.
Muangchana C; Henprasertthae N; Nurach K; Theppang K; Yoocharoen P; Varinsathien P; Techathawat S; Sanohsieng S; Anantapreecha S
Vaccine; 2012 Jan; 30(2):361-7. PubMed ID: 22075090
[TBL] [Abstract][Full Text] [Related]
35. A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.
Lyons A; Kanesa-thasan N; Kuschner RA; Eckels KH; Putnak R; Sun W; Burge R; Towle AC; Wilson P; Tauber E; Vaughn DW
Vaccine; 2007 Apr; 25(17):3445-53. PubMed ID: 17241714
[TBL] [Abstract][Full Text] [Related]
36. Japanese encephalitis for a reference to international travelers.
Oya A; Kurane I
J Travel Med; 2007; 14(4):259-68. PubMed ID: 17617849
[TBL] [Abstract][Full Text] [Related]
37. Japanese encephalitis revisited.
Diagana M; Preux PM; Dumas M
J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451
[TBL] [Abstract][Full Text] [Related]
38. Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: A retrospective epidemiological study.
Zhang X; Jin N; Tu A; Dong M; Shi T; Ren X; Liu S; Zhao X; Liu J; Wu Z; Li Y; Wu D; Wang H; Wang H; Hu Y; Zhang B; Wang W; Meng L
J Med Virol; 2023 May; 95(5):e28782. PubMed ID: 37212323
[TBL] [Abstract][Full Text] [Related]
39. [Surveillance on Japanese encephalitis in Henan province, 2006 - 2010].
Tang XY; Kang K; Li XL; Chen HM; Xu BL
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1128-30. PubMed ID: 22336549
[TBL] [Abstract][Full Text] [Related]
40. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines].
Fang QA; Chen BQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
